Insulin glargine and lixisenatide Subcutaneous and Levetiracetam
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Levetiracetam and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: levetiracetam
Brand name: Keppra, Keppra XR, Roweepra, Spritam, Roweepra XR
Synonyms: LevETIRAcetam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Levetiracetam Extended-Release Tablets
- Insulin glargine and lixisenatide Subcutaneous-Levetiracetam Injection
- Insulin glargine and lixisenatide Subcutaneous-Levetiracetam Injection, Concentrate
- Insulin glargine and lixisenatide Subcutaneous-Levetiracetam Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Levetiracetam Oral Solution
- Insulin glargine and lixisenatide Subcutaneous-Levetiracetam Solution
- Levetiracetam-Insulin glargine, recombinant Subcutaneous
- Levetiracetam-Insulin glulisine
- Levetiracetam-Insulin Glulisine (Cartridges and Pens)
- Levetiracetam-Insulin Glulisine (Vials)
- Levetiracetam-Insulin glulisine Subcutaneous
- Levetiracetam-Insulin human inhaled Inhalation